Healthcare Sector Stocks
The Healthcare sector has a total of 1054 stocks, with a combined market cap of $9.47 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 50.45.
Market Cap
9.47T
Revenue
4.67T
Profits
187.63B
PE Ratio
50.45
Profit Margin
4.02%
Dividend Yield
0.38%
1053 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.03T | -0.54% | 406,386 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 662.72B | -0.08% | 571,351 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 459.45B | -0.66% | 316,738 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 370.89B | -0.86% | 683,050 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 358.96B | 0.06% | 416,550 | 450.53B |
| 6 | NVS | Novartis AG | 307.13B | 0.40% | 298,584 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 250.86B | 1.75% | 519,913 | 61.37B |
| 8 | AMGN | Amgen Inc. | 239.19B | -0.09% | 166,072 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 224.65B | -0.16% | 290,182 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 206.96B | 0.83% | 2,570,456 | 50.34B |
| 11 | ABT | Abbott Laboratories | 188.78B | -1.24% | 428,329 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 184.95B | -0.30% | 455,756 | 30.46B |
| 13 | PFE | Pfizer Inc. | 163.58B | -1.10% | 5,972,208 | 63.70B |
| 14 | DHR | Danaher Corporation | 145.83B | -1.17% | 241,461 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 141.18B | 0.04% | 75,698 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 137.86B | -0.25% | 1,135,779 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 130.47B | -0.69% | 161,844 | 11.03B |
| 18 | CVS | CVS Health Corporation | 123.00B | -1.09% | 675,263 | 412.65B |
| 19 | SYK | Stryker Corporation | 119.04B | -0.59% | 251,136 | 25.84B |
| 20 | MDT | Medtronic plc | 117.18B | -0.68% | 873,925 | 37.54B |
| 21 | MCK | McKesson Corporation | 108.01B | 0.18% | 56,381 | 410.98B |
| 22 | SNY | Sanofi | 107.16B | 0.40% | 371,966 | 55.89B |
| 23 | GSK | GSK plc | 100.74B | 0.24% | 568,910 | 44.05B |
| 24 | ELV | Elevance Health, Inc. | 88.04B | 0.03% | 78,238 | 201.11B |
| 25 | HCA | HCA Healthcare, Inc. | 87.72B | 0.77% | 184,517 | 78.01B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 84.48B | -0.71% | 59,921 | 15.53B |
| 27 | CI | The Cigna Group | 74.64B | -0.13% | 68,954 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 69.13B | -1.39% | 1,239,566 | 21.00B |
| 29 | ARGX | argenx SE | 65.29B | 0.53% | 48,104 | 5.32B |
| 30 | COR | Cencora, Inc. | 64.34B | 0.24% | 91,397 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 59.46B | 1.09% | 741,553 | 28.42B |
| 32 | MRNA | Moderna, Inc. | 58.56B | -2.75% | 2,739,737 | 2.23B |
| 33 | CAH | Cardinal Health, Inc. | 57.44B | 0.61% | 152,987 | 254.25B |
| 34 | EW | Edwards Lifesciences Corporation | 51.68B | -1.28% | 128,800 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 50.69B | -0.75% | 123,839 | 22.48B |
| 36 | HUM | Humana Inc. | 48.63B | 1.00% | 44,180 | 145.68B |
| 37 | MDLN | Medline Inc. | 47.38B | -0.72% | 375,861 | 29.94B |
| 38 | NTRA | Natera, Inc. | 46.49B | -0.82% | 81,841 | 2.71B |
| 39 | VEEV | Veeva Systems Inc. | 46.17B | 1.59% | 188,695 | 3.46B |
| 40 | RVMD | Revolution Medicines, Inc. | 45.01B | 0.38% | 119,876 | - |
| 41 | IQV | IQVIA Holdings Inc. | 43.56B | 0.30% | 132,122 | 16.98B |
| 42 | HLN | Haleon plc | 43.54B | -0.71% | 6,122,865 | 14.80B |
| 43 | TEVA | Teva Pharmaceutical Industries Limited | 42.72B | -2.21% | 688,013 | 17.32B |
| 44 | IDXX | IDEXX Laboratories, Inc. | 42.03B | -1.02% | 33,595 | 4.55B |
| 45 | A | Agilent Technologies, Inc. | 42.02B | -1.54% | 190,520 | 7.37B |
| 46 | ONC | BeOne Medicines AG | 41.10B | -0.07% | 13,964 | 6.13B |
| 47 | WAT | Waters Corporation | 40.19B | -0.77% | 34,300 | 4.64B |
| 48 | RPRX | Royalty Pharma plc | 36.28B | -0.02% | 295,728 | 2.54B |
| 49 | ALNY | Alnylam Pharmaceuticals, Inc. | 35.47B | -0.86% | 196,264 | 4.80B |
| 50 | ALC | Alcon Inc. | 35.31B | 0.01% | 130,916 | 10.86B |
| 51 | DXCM | DexCom, Inc. | 33.90B | 0.16% | 132,210 | 4.97B |
| 52 | CNC | Centene Corporation | 33.45B | 0.56% | 364,805 | 180.30B |
| 53 | RMD | ResMed Inc. | 33.05B | -0.75% | 77,985 | 5.65B |
| 54 | BIIB | Biogen Inc. | 32.80B | -0.30% | 57,201 | 10.03B |
| 55 | ILMN | Illumina, Inc. | 32.00B | -0.61% | 129,208 | 4.49B |
| 56 | ZTS | Zoetis Inc. | 31.19B | -0.89% | 523,830 | 9.53B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 31.17B | -2.21% | 390,026 | 21.27B |
| 58 | INSM | Insmed Incorporated | 27.69B | 0.12% | 311,134 | 1.14B |
| 59 | MTD | Mettler-Toledo International Inc. | 26.95B | -1.65% | 12,096 | 4.13B |
| 60 | LH | Labcorp Holdings Inc. | 26.89B | -0.04% | 32,991 | 14.35B |
| 61 | DGX | Quest Diagnostics Incorporated | 26.44B | -0.52% | 26,403 | 11.56B |
| 62 | PHG | Koninklijke Philips N.V. | 25.90B | -1.90% | 187,696 | 20.18B |
| 63 | INCY | Incyte Corporation | 25.84B | -1.03% | 87,792 | 5.82B |
| 64 | BNTX | BioNTech SE | 25.79B | -1.12% | 112,163 | 3.03B |
| 65 | ROIV | Roivant Sciences Ltd. | 24.48B | -0.85% | 235,651 | 7.53M |
| 66 | WST | West Pharmaceutical Services, Inc. | 23.92B | -0.79% | 17,340 | 3.33B |
| 67 | STE | STERIS plc | 22.23B | -1.03% | 26,865 | 6.04B |
| 68 | GH | Guardant Health, Inc. | 21.72B | -0.75% | 75,336 | 1.18B |
| 69 | THC | Tenet Healthcare Corporation | 21.16B | 1.66% | 54,880 | 21.81B |
| 70 | UTHR | United Therapeutics Corporation | 20.62B | -2.27% | 95,093 | 3.15B |
| 71 | GMAB | Genmab A/S | 20.14B | 0.37% | 112,943 | 4.13B |
| 72 | VTRS | Viatris Inc. | 19.54B | -0.47% | 415,070 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.90B | -0.41% | 167,332 | 8.51B |
| 74 | ASND | Ascendis Pharma A/S | 17.69B | 0.74% | 79,960 | 1.20B |
| 75 | MEDP | Medpace Holdings, Inc. | 16.63B | 0.47% | 19,577 | 2.78B |
| 76 | NBIX | Neurocrine Biosciences, Inc. | 16.01B | -0.18% | 92,289 | 3.37B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.86B | -0.54% | 82,988 | 4.60B |
| 78 | SOLV | Solventum Corporation | 15.72B | 0.50% | 52,762 | 8.31B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 14.89B | -0.44% | 64,396 | 713.07M |
| 80 | EXEL | Exelixis, Inc. | 14.63B | 0.91% | 157,248 | 2.44B |
| 81 | RVTY | Revvity, Inc. | 14.39B | -1.54% | 198,668 | 2.91B |
| 82 | CRL | Charles River Laboratories International, Inc. | 13.75B | -1.28% | 85,127 | 4.00B |
| 83 | COO | The Cooper Companies, Inc. | 13.65B | 0.39% | 358,334 | 4.23B |
| 84 | BAX | Baxter International Inc. | 13.14B | -1.13% | 354,597 | 11.47B |
| 85 | BMRN | BioMarin Pharmaceutical Inc. | 13.02B | 0.42% | 159,240 | 3.41B |
| 86 | SMMT | Summit Therapeutics Inc. | 12.79B | 9.79% | 2,790,211 | - |
| 87 | PEN | Penumbra, Inc. | 12.71B | -0.07% | 3,632 | 1.50B |
| 88 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.69B | 0.45% | 12,251 | 1.28B |
| 89 | ICLR | ICON Public Limited Company | 12.43B | 0.79% | 132,788 | 8.29B |
| 90 | HALO | Halozyme Therapeutics, Inc. | 12.42B | -0.20% | 191,503 | 1.66B |
| 91 | BTSG | BrightSpring Health Services, Inc. | 12.34B | -1.69% | 94,057 | 14.37B |
| 92 | FMS | Fresenius Medical Care AG | 12.09B | -0.22% | 118,039 | 22.19B |
| 93 | CORT | Corcept Therapeutics Incorporated | 12.09B | 1.28% | 49,019 | 830.81M |
| 94 | ELAN | Elanco Animal Health Incorporated | 12.08B | -2.03% | 332,604 | 5.02B |
| 95 | SNN | Smith & Nephew plc | 12.07B | 0.73% | 474,254 | 6.30B |
| 96 | EHC | Encompass Health Corporation | 11.98B | 0.17% | 18,223 | 6.21B |
| 97 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.91B | -1.25% | 82,391 | 669.50M |
| 98 | DVA | DaVita Inc. | 11.39B | -0.43% | 34,128 | 14.01B |
| 99 | TECH | Bio-Techne Corporation | 11.34B | 0.06% | 884,900 | 1.22B |
| 100 | ALGN | Align Technology, Inc. | 11.33B | 0.20% | 71,530 | 4.14B |
| 101 | TEM | Tempus AI, Inc. | 11.28B | 0.90% | 1,056,375 | 1.43B |
| 102 | AXSM | Axsome Therapeutics, Inc. | 10.96B | -0.36% | 48,903 | 776.57M |
| 103 | KRYS | Krystal Biotech, Inc. | 10.95B | 0.23% | 21,648 | 440.48M |
| 104 | GKOS | Glaukos Corporation | 10.62B | 0.37% | 41,073 | 612.84M |
| 105 | GMED | Globus Medical, Inc. | 10.61B | -2.06% | 120,349 | 3.14B |
| 106 | MOH | Molina Healthcare, Inc. | 10.49B | -0.66% | 29,567 | 42.47B |
| 107 | ABVX | ABIVAX Société Anonyme | 10.48B | 1.93% | 89,283 | 5.67M |
| 108 | BIO | Bio-Rad Laboratories, Inc. | 10.26B | -1.25% | 10,305 | 2.59B |
| 109 | RDY | Dr. Reddy's Laboratories Limited | 10.24B | -1.81% | 530,313 | 3.50B |
| 110 | PODD | Insulet Corporation | 10.22B | -0.56% | 108,947 | 3.05B |
| 111 | APGE | Apogee Therapeutics, Inc. | 10.19B | - | - | - |
| 112 | CYTK | Cytokinetics, Incorporated | 10.17B | 1.70% | 212,353 | 67.67M |
| 113 | HSIC | Henry Schein, Inc. | 10.07B | -0.07% | 33,772 | 13.60B |
| 114 | ENSG | The Ensign Group, Inc. | 9.97B | -0.12% | 16,680 | 5.49B |
| 115 | AVTR | Avantor, Inc. | 9.93B | 0.20% | 760,073 | 6.56B |
| 116 | PRAX | Praxis Precision Medicines, Inc. | 9.91B | -0.75% | 25,877 | 7.46M |
| 117 | UHS | Universal Health Services, Inc. | 9.90B | 0.30% | 40,979 | 18.11B |
| 118 | IONS | Ionis Pharmaceuticals, Inc. | 9.77B | -4.09% | 641,943 | 874.09M |
| 119 | KYMR | Kymera Therapeutics, Inc. | 9.77B | -0.95% | 74,569 | 105.00M |
| 120 | OSCR | Oscar Health, Inc. | 9.68B | 3.56% | 459,056 | 15.32B |
| 121 | RGEN | Repligen Corporation | 9.49B | -2.74% | 62,731 | 785.10M |
| 122 | PTGX | Protagonist Therapeutics, Inc. | 9.34B | -1.14% | 24,758 | 281.99M |
| 123 | QGEN | Qiagen N.V. | 9.01B | -1.38% | 190,797 | 2.10B |
| 124 | PCVX | Vaxcyte, Inc. | 9.00B | -1.79% | 58,774 | - |
| 125 | BRKR | Bruker Corporation | 8.82B | -1.90% | 105,968 | 3.50B |
| 126 | IBRX | ImmunityBio, Inc. | 8.45B | 0.31% | 699,615 | 165.79M |
| 127 | TGTX | TG Therapeutics, Inc. | 8.20B | 1.55% | 213,800 | 799.54M |
| 128 | ATR | AptarGroup, Inc. | 8.17B | -1.45% | 20,781 | 3.93B |
| 129 | HQY | HealthEquity, Inc. | 8.15B | -0.01% | 30,337 | 1.36B |
| 130 | TWST | Twist Bioscience Corporation | 8.06B | -1.89% | 124,371 | 431.80M |
| 131 | IMVT | Immunovant, Inc. | 8.05B | -1.29% | 180,205 | - |
| 132 | ALKS | Alkermes plc | 7.94B | -0.78% | 65,352 | 1.67B |
| 133 | TXG | 10x Genomics, Inc. | 7.93B | -1.27% | 273,513 | 616.91M |
| 134 | SYRE | Spyre Therapeutics, Inc. | 7.67B | -0.08% | 104,874 | - |
| 135 | HNGE | Hinge Health, Inc. | 7.31B | -1.43% | 100,333 | 720.06M |
| 136 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.27B | 0.15% | 23,583 | 239.92M |
| 137 | GRFS | Grifols, S.A. | 6.87B | 0.77% | 118,763 | 8.48B |
| 138 | SRRK | Scholar Rock Holding Corporation | 6.79B | -0.61% | 42,759 | - |
| 139 | CHE | Chemed Corporation | 6.79B | -0.46% | 53,802 | 2.60B |
| 140 | CAI | Caris Life Sciences, Inc. | 6.73B | -3.99% | 872,378 | 989.61M |
| 141 | PACS | PACS Group, Inc. | 6.71B | -1.69% | 48,207 | 5.55B |
| 142 | HIMS | Hims & Hers Health, Inc. | 6.63B | -0.91% | 1,847,856 | 2.58B |
| 143 | MMED | MiniMed Group, Inc. | 6.61B | -1.01% | 102,124 | 3.22B |
| 144 | BLTE | Belite Bio, Inc | 6.60B | 1.99% | 12,490 | - |
| 145 | LNTH | Lantheus Holdings, Inc. | 6.59B | 0.13% | 60,804 | 1.56B |
| 146 | CGON | CG Oncology, Inc. | 6.58B | -0.52% | 17,836 | 6.23M |
| 147 | MIRM | Mirum Pharmaceuticals, Inc. | 6.49B | 0.05% | 36,474 | 618.07M |
| 148 | TVTX | Travere Therapeutics, Inc. | 6.40B | 0.92% | 83,098 | 591.33M |
| 149 | BLCO | Bausch + Lomb Corporation | 6.38B | -0.83% | 27,987 | 5.32B |
| 150 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.26B | 0.49% | 80,039 | 840.85M |
| 151 | AMRX | Amneal Pharmaceuticals, Inc. | 6.25B | -0.66% | 88,096 | 3.12B |
| 152 | LQDA | Liquidia Corporation | 6.24B | 0.04% | 136,279 | 450.91M |
| 153 | ORKA | Oruka Therapeutics, Inc. | 6.05B | -0.33% | 89,368 | - |
| 154 | PTCT | PTC Therapeutics, Inc. | 6.01B | 0.25% | 32,561 | 1.01B |
| 155 | TFX | Teleflex Incorporated | 5.95B | -0.34% | 29,504 | 2.25B |
| 156 | COGT | Cogent Biosciences, Inc. | 5.95B | -0.87% | 73,872 | - |
| 157 | DNTH | Dianthus Therapeutics, Inc. | 5.95B | 0.08% | 34,725 | 1.90M |
| 158 | RDNT | RadNet, Inc. | 5.89B | -1.12% | 36,588 | 2.27B |
| 159 | XENE | Xenon Pharmaceuticals Inc. | 5.83B | 0.12% | 32,267 | 7.50M |
| 160 | STVN | Stevanato Group S.p.A. | 5.68B | 0.29% | 4,182 | 1.40B |
| 161 | ERAS | Erasca, Inc. | 5.68B | -0.86% | 151,201 | - |
| 162 | LGND | Ligand Pharmaceuticals Incorporated | 5.65B | -1.14% | 22,338 | 290.54M |
| 163 | CRSP | CRISPR Therapeutics AG | 5.44B | -1.25% | 164,207 | 13.39M |
| 164 | SHC | Sotera Health Company | 5.37B | -0.69% | 92,533 | 1.22B |
| 165 | MMSI | Merit Medical Systems, Inc. | 5.36B | -0.47% | 21,602 | 1.58B |
| 166 | DFTX | Definium Therapeutics, Inc. | 5.08B | -2.83% | 268,561 | - |
| 167 | ACAD | ACADIA Pharmaceuticals Inc. | 4.98B | -0.17% | 102,771 | 1.14B |
| 168 | LFST | LifeStance Health Group, Inc. | 4.91B | -0.31% | 450,541 | 1.58B |
| 169 | WAY | Waystar Holding Corp. | 4.91B | -0.51% | 66,629 | 1.21B |
| 170 | PBLS | Parabilis Medicines, Inc. | 4.90B | -1.06% | 31,107 | 148.00K |
| 171 | DOCS | Doximity, Inc. | 4.85B | 3.46% | 186,646 | 655.57M |
| 172 | CELC | Celcuity Inc. | 4.75B | 0.93% | 70,508 | - |
| 173 | DYN | Dyne Therapeutics, Inc. | 4.72B | 0.48% | 73,734 | - |
| 174 | HAE | Haemonetics Corporation | 4.68B | 0.03% | 24,869 | 1.35B |
| 175 | EWTX | Edgewise Therapeutics, Inc. | 4.56B | -0.02% | 100,842 | - |
| 176 | LIVN | LivaNova PLC | 4.54B | -0.04% | 14,404 | 1.47B |
| 177 | BLLN | BillionToOne, Inc. | 4.53B | -0.20% | 53,314 | 397.41M |
| 178 | NVST | Envista Holdings Corporation | 4.42B | 0.55% | 213,693 | 2.86B |
| 179 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.38B | 1.13% | 97,817 | -665.00K |
| 180 | ELVN | Enliven Therapeutics, Inc. | 4.37B | 1.05% | 152,358 | - |
| 181 | CON | Concentra Group Holdings Parent, Inc. | 4.34B | 0.03% | 32,812 | 2.29B |
| 182 | HTFL | HeartFlow, Inc. | 4.28B | -1.50% | 85,773 | 212.07M |
| 183 | ITGR | Integer Holdings Corporation | 4.26B | 0.08% | 69,377 | 1.84B |
| 184 | LEGN | Legend Biotech Corporation | 4.21B | -0.78% | 168,673 | 1.27B |
| 185 | ICUI | ICU Medical, Inc. | 4.20B | -1.00% | 34,962 | 2.16B |
| 186 | INDV | Indivior Pharmaceuticals, Inc. | 4.11B | -0.58% | 195,523 | 1.33B |
| 187 | RLAY | Relay Therapeutics, Inc. | 4.07B | 0.22% | 132,598 | 10.35M |
| 188 | IRTC | iRhythm Holdings, Inc. | 4.05B | 0.41% | 91,236 | 825.34M |
| 189 | MANE | Veradermics, Incorporated | 4.03B | -2.12% | 58,762 | - |
| 190 | TLX | Telix Pharmaceuticals Limited | 3.96B | 2.40% | 32,063 | 890.79M |
| 191 | VKTX | Viking Therapeutics, Inc. | 3.96B | 1.36% | 247,980 | - |
| 192 | IOVA | Iovance Biotherapeutics, Inc. | 3.95B | 1.04% | 1,286,268 | 324.97M |
| 193 | ADPT | Adaptive Biotechnologies Corporation | 3.89B | -1.09% | 210,912 | 308.08M |
| 194 | PLSE | Pulse Biosciences, Inc. | 3.88B | 3.26% | 87,511 | 1.19M |
| 195 | IDYA | IDEAYA Biosciences, Inc. | 3.87B | -0.22% | 56,107 | 234.13M |
| 196 | TNGX | Tango Therapeutics, Inc. | 3.80B | 0.90% | 110,655 | 53.81M |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.78B | -0.67% | 76,692 | 117.00M |
| 198 | ABCL | AbCellera Biologics Inc. | 3.71B | 0.70% | 571,635 | 66.17M |
| 199 | TARS | Tarsus Pharmaceuticals, Inc. | 3.62B | -0.41% | 73,589 | 606.33M |
| 200 | OGN | Organon & Co. | 3.61B | -0.11% | 1,750,074 | 6.13B |
| 201 | DNLI | Denali Therapeutics Inc. | 3.61B | -1.14% | 234,301 | 3.60M |
| 202 | OPCH | Option Care Health, Inc. | 3.60B | 0.80% | 129,453 | 5.69B |
| 203 | VCYT | Veracyte, Inc. | 3.57B | -1.14% | 60,222 | 561.90M |
| 204 | GRAL | GRAIL, Inc. | 3.56B | -1.07% | 23,936 | 165.26M |
| 205 | NHC | National HealthCare Corporation | 3.40B | -0.11% | 11,745 | 1.56B |
| 206 | GPCR | Structure Therapeutics Inc. | 3.34B | -1.97% | 31,608 | - |
| 207 | QURE | uniQure N.V. | 3.12B | -2.66% | 128,763 | 18.67M |
| 208 | RGC | Regencell Bioscience Holdings Limited | 3.07B | -1.74% | 135,259 | - |
| 209 | IMNM | Immunome, Inc. | 3.07B | -1.21% | 44,813 | 4.02M |
| 210 | CLDX | Celldex Therapeutics, Inc. | 3.07B | -1.11% | 49,162 | 158.00K |
| 211 | NAMS | NewAmsterdam Pharma Company N.V. | 3.06B | 0.04% | 42,166 | 7.12M |
| 212 | IRON | Disc Medicine, Inc. | 3.05B | -0.76% | 28,343 | - |
| 213 | ZLAB | Zai Lab Limited | 3.00B | 0.87% | 120,729 | 449.61M |
| 214 | ARQT | Arcutis Biotherapeutics, Inc. | 2.99B | -0.34% | 83,982 | 463.98M |
| 215 | MBX | MBX Biosciences, Inc. | 2.98B | 1.63% | 57,942 | - |
| 216 | TMDX | TransMedics Group, Inc. | 2.97B | 1.45% | 30,122 | 668.47M |
| 217 | WRBY | Warby Parker Inc. | 2.93B | -0.79% | 272,684 | 911.61M |
| 218 | AVAH | Aveanna Healthcare Holdings Inc. | 2.86B | -0.61% | 173,560 | 2.60B |
| 219 | SLS | SELLAS Life Sciences Group, Inc. | 2.86B | - | 960,067 | - |
| 220 | BKD | Brookdale Senior Living Inc. | 2.84B | -0.17% | 153,959 | 2.93B |
| 221 | BEAM | Beam Therapeutics Inc. | 2.84B | -3.00% | 107,350 | 156.04M |
| 222 | ALHC | Alignment Healthcare, Inc. | 2.78B | -1.47% | 317,507 | 4.58B |
| 223 | ATAI | AtaiBeckley Inc. | 2.75B | 0.88% | 3,773,629 | 4.47M |
| 224 | PRVA | Privia Health Group, Inc. | 2.65B | 0.14% | 32,310 | 2.36B |
| 225 | NRIX | Nurix Therapeutics, Inc. | 2.64B | -1.67% | 48,137 | 36.77M |
| 226 | ATRC | AtriCure, Inc. | 2.62B | -2.11% | 56,802 | 569.62M |
| 227 | WGS | GeneDx Holdings Corp. | 2.60B | 0.44% | 57,769 | 454.43M |
| 228 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.59B | -0.49% | 368,204 | 940.61M |
| 229 | VRDN | Viridian Therapeutics, Inc. | 2.58B | -0.13% | 74,799 | 71.13M |
| 230 | AXGN | Axogen, Inc. | 2.56B | -1.30% | 124,716 | 251.17M |
| 231 | ACHC | Acadia Healthcare Company, Inc. | 2.56B | -1.01% | 79,104 | 3.37B |
| 232 | PGEN | Precigen, Inc. | 2.54B | 1.21% | 389,188 | 85.72M |
| 233 | NEOG | Neogen Corporation | 2.54B | -1.48% | 87,270 | 870.40M |
| 234 | SUPN | Supernus Pharmaceuticals, Inc. | 2.53B | -1.01% | 45,222 | 830.44M |
| 235 | CDNA | CareDx, Inc. | 2.53B | -1.57% | 71,731 | 458.09M |
| 236 | NKTR | Nektar Therapeutics | 2.52B | 1.48% | 55,420 | 54.59M |
| 237 | VERA | Vera Therapeutics, Inc. | 2.52B | -2.02% | 93,825 | - |
| 238 | PBH | Prestige Consumer Healthcare Inc. | 2.51B | 0.45% | 12,052 | 1.10B |
| 239 | BHC | Bausch Health Companies Inc. | 2.51B | -1.61% | 214,370 | 10.85B |
| 240 | MLYS | Mineralys Therapeutics, Inc. | 2.50B | -2.58% | 271,276 | - |
| 241 | HRMY | Harmony Biosciences Holdings, Inc. | 2.50B | 0.05% | 114,837 | 959.90M |
| 242 | GRDN | Guardian Pharmacy Services, Inc. | 2.47B | -0.13% | 11,016 | 1.46B |
| 243 | PHVS | Pharvaris N.V. | 2.47B | -0.03% | 25,110 | - |
| 244 | NUVB | Nuvation Bio Inc. | 2.44B | 0.07% | 391,373 | 169.90M |
| 245 | SRPT | Sarepta Therapeutics, Inc. | 2.41B | -1.53% | 343,558 | 1.97B |
| 246 | BHVN | Biohaven Ltd. | 2.40B | 1.08% | 144,990 | - |
| 247 | OCUL | Ocular Therapeutix, Inc. | 2.39B | -0.09% | 108,815 | 52.06M |
| 248 | TRVI | Trevi Therapeutics, Inc. | 2.39B | -1.58% | 277,586 | - |
| 249 | KOD | Kodiak Sciences Inc. | 2.34B | -0.61% | 36,713 | - |
| 250 | RAPP | Rapport Therapeutics, Inc. | 2.32B | -0.60% | 15,397 | 20.00M |
| 251 | XRAY | DENTSPLY SIRONA Inc. | 2.27B | 0.80% | 498,883 | 3.64B |
| 252 | UFPT | UFP Technologies, Inc. | 2.26B | -0.23% | 21,192 | 631.64M |
| 253 | CLOV | Clover Health Investments, Corp. | 2.26B | -1.16% | 464,278 | 2.48B |
| 254 | TRLV | Trulieve Cannabis Corp. | 2.24B | -0.34% | 227,075 | 1.14B |
| 255 | MESO | Mesoblast Limited | 2.22B | -1.79% | 15,754 | 120.25M |
| 256 | NEO | NeoGenomics, Inc. | 2.21B | -1.32% | 255,926 | 766.30M |
| 257 | PVLA | Palvella Therapeutics, Inc. | 2.18B | -0.95% | 16,500 | - |
| 258 | ZBIO | Zenas BioPharma, Inc. | 2.18B | 0.81% | 54,866 | 1.00M |
| 259 | ESTA | Establishment Labs Holdings Inc. | 2.17B | -2.60% | 35,699 | 245.82M |
| 260 | ZYME | Zymeworks Inc. | 2.17B | -1.42% | 53,671 | 37.13M |
| 261 | ADUS | Addus HomeCare Corporation | 2.16B | -0.19% | 51,103 | 1.48B |
| 262 | URGN | UroGen Pharma Ltd. | 2.16B | -0.70% | 21,976 | 188.73M |
| 263 | AUPH | Aurinia Pharmaceuticals Inc. | 2.15B | -0.80% | 48,670 | 311.51M |
| 264 | MD | Pediatrix Medical Group, Inc. | 2.12B | -0.52% | 35,248 | 1.95B |
| 265 | ADMA | ADMA Biologics, Inc. | 2.12B | -0.53% | 109,793 | 512.28M |
| 266 | HCM | HUTCHMED (China) Limited | 2.11B | 14.20% | 161,313 | 549.12M |
| 267 | ALMR | Alamar Biosciences, Inc. | 2.10B | -0.56% | 4,464 | 100.42M |
| 268 | GENB | Generate Biomedicines, Inc. | 2.10B | 0.37% | 195,169 | 26.48M |
| 269 | VCEL | Vericel Corporation | 2.08B | -0.83% | 15,644 | 306.30M |
| 270 | NBTX | Nanobiotix S.A. | 2.07B | -2.74% | 18,522 | 38.27M |
| 271 | KLRA | Kailera Therapeutics, Inc. | 2.06B | 0.19% | 81,881 | - |
| 272 | NVCR | NovoCure Limited | 2.05B | -1.49% | 69,476 | 699.19M |
| 273 | COAG | Hemab Therapeutics Holdings, Inc. | 2.03B | -2.60% | 24,556 | - |
| 274 | AGIO | Agios Pharmaceuticals, Inc. | 2.03B | -0.53% | 50,397 | 98.34M |
| 275 | PGNY | Progyny, Inc. | 2.01B | -0.23% | 50,669 | 1.31B |
| 276 | KARD | Kardigan, Inc. | 2.00B | -2.55% | 36,088 | - |
| 277 | PRGO | Perrigo Company plc | 1.99B | -1.04% | 100,625 | 4.14B |
| 278 | XNCR | Xencor, Inc. | 1.99B | -0.63% | 106,407 | 104.97M |
| 279 | BFLY | Butterfly Network, Inc. | 1.97B | -2.63% | 553,361 | 112.14M |
| 280 | STOK | Stoke Therapeutics, Inc. | 1.96B | -0.26% | 47,532 | 27.59M |
| 281 | VIR | Vir Biotechnology, Inc. | 1.96B | 0.70% | 185,192 | 303.23M |
| 282 | ASTH | Astrana Health, Inc. | 1.93B | -2.05% | 32,240 | 3.84B |
| 283 | ALVO | Alvotech | 1.93B | 1.31% | 81,414 | 494.61M |
| 284 | GHRS | GH Research PLC | 1.90B | -1.14% | 7,975 | - |
| 285 | IMCR | Immunocore Holdings plc | 1.89B | -1.77% | 9,287 | 430.78M |
| 286 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.89B | -1.63% | 238,726 | 208.78M |
| 287 | LKFT | Lakefront Biotherapeutics NV | 1.88B | 0.52% | 51,769 | 1.13B |
| 288 | LMAT | LeMaitre Vascular, Inc. | 1.85B | -0.82% | 15,101 | 262.43M |
| 289 | SNDX | Syndax Pharmaceuticals, Inc. | 1.85B | -0.53% | 48,467 | 252.25M |
| 290 | INBX | Inhibrx Biosciences, Inc. | 1.84B | -0.22% | 22,304 | 1.30M |
| 291 | TSHA | Taysha Gene Therapies, Inc. | 1.82B | -0.89% | 138,854 | 5.49M |
| 292 | INSP | Inspire Medical Systems, Inc. | 1.82B | -0.21% | 19,333 | 898.74M |
| 293 | SLBT | SL Science Holding Limited | 1.81B | -3.93% | 26,979 | 3.27M |
| 294 | SGRY | Surgery Partners, Inc. | 1.80B | -0.68% | 276,534 | 3.37B |
| 295 | CMPS | COMPASS Pathways plc | 1.80B | -1.74% | 664,098 | - |
| 296 | RXRX | Recursion Pharmaceuticals, Inc. | 1.79B | -1.48% | 2,100,563 | 54.86M |
| 297 | PSNL | Personalis, Inc. | 1.78B | -0.39% | 514,224 | 69.67M |
| 298 | SNDA | Sonida Senior Living, Inc. | 1.77B | -0.56% | 85,276 | 481.07M |
| 299 | NTLA | Intellia Therapeutics, Inc. | 1.76B | -1.72% | 384,532 | 59.51M |
| 300 | FTRE | Fortrea Holdings Inc. | 1.75B | 0.16% | 48,220 | 2.68B |
| 301 | ETON | Eton Pharmaceuticals, Inc. | 1.74B | -1.74% | 29,785 | 105.60M |
| 302 | BLFS | BioLife Solutions, Inc. | 1.73B | -1.68% | 40,264 | 106.69M |
| 303 | SEPN | Septerna, Inc. | 1.72B | -1.53% | 35,325 | 98.88M |
| 304 | FRNM | Freenome, Inc. | 1.72B | 0.31% | 42,920 | 35.41M |
| 305 | DMRA | Damora Therapeutics, Inc. | 1.71B | -1.70% | 23,539 | - |
| 306 | BRVE | Braveheart Bio, Inc. | 1.70B | -1.41% | 11,555 | - |
| 307 | NVAX | Novavax, Inc. | 1.68B | -1.16% | 580,284 | 413.80M |
| 308 | ANAB | AnaptysBio, Inc. | 1.68B | 1.47% | 13,728 | 232.39M |
| 309 | AAPG | Ascentage Pharma Group International | 1.61B | 2.91% | 6,076 | 94.61M |
| 310 | TRAX | First Tracks Biotherapeutics, Inc. | 1.61B | -0.40% | 51,023 | - |
| 311 | OMCL | Omnicell, Inc. | 1.58B | -0.13% | 33,257 | 1.25B |
| 312 | PAHC | Phibro Animal Health Corporation | 1.57B | -2.83% | 12,712 | 1.52B |
| 313 | LBRX | LB Pharmaceuticals Inc | 1.57B | -1.80% | 21,217 | - |
| 314 | ANIP | ANI Pharmaceuticals, Inc. | 1.56B | -0.14% | 12,100 | 978.38M |
| 315 | APMD | Apnimed, Inc. | 1.56B | 0.86% | 44,662 | 120.15M |
| 316 | AVLN | Avalyn Pharma Inc. | 1.55B | -1.57% | 18,017 | - |
| 317 | XERS | Xeris Biopharma Holdings, Inc. | 1.55B | -0.76% | 136,858 | 335.41M |
| 318 | SDGR | Schrödinger, Inc. | 1.54B | -1.13% | 92,213 | 259.04M |
| 319 | ARDT | Ardent Health, Inc. | 1.54B | -0.18% | 27,164 | 6.41B |
| 320 | INVA | Innoviva, Inc. | 1.53B | -0.52% | 25,474 | 440.00M |
| 321 | BCAX | Bicara Therapeutics Inc. | 1.53B | -1.70% | 21,199 | - |
| 322 | AVBP | ArriVent BioPharma, Inc. | 1.52B | 0.88% | 34,489 | - |
| 323 | HCSG | Healthcare Services Group, Inc. | 1.50B | 0.39% | 27,961 | 1.86B |
| 324 | TYRA | Tyra Biosciences, Inc. | 1.49B | -0.48% | 21,117 | - |
| 325 | ABSI | Absci Corporation | 1.49B | -1.25% | 191,591 | 1.56M |
| 326 | AKTS | Aktis Oncology, Inc. | 1.49B | -0.72% | 14,178 | 10.06M |
| 327 | REPL | Replimune Group, Inc. | 1.49B | -1.28% | 77,018 | - |
| 328 | MAZE | Maze Therapeutics, Inc. | 1.48B | -0.45% | 42,481 | 20.00M |
| 329 | KMTS | Kestra Medical Technologies, Ltd. | 1.47B | -2.33% | 17,513 | 95.13M |
| 330 | CNMD | CONMED Corporation | 1.47B | -0.93% | 10,054 | 1.37B |
| 331 | HROW | Harrow, Inc. | 1.45B | -0.97% | 19,988 | 275.59M |
| 332 | RARE | Ultragenyx Pharmaceutical Inc. | 1.45B | -44.52% | 10,028,271 | 717.00M |
| 333 | INNV | InnovAge Holding Corp. | 1.44B | -1.67% | 8,746 | 949.17M |
| 334 | AGL | agilon health, inc. | 1.44B | -2.15% | 8,610 | 5.92B |
| 335 | VOR | Vor Biopharma Inc. | 1.44B | -2.02% | 90,674 | - |
| 336 | ANRO | Alto Neuroscience, Inc. | 1.43B | -0.55% | 24,709 | - |
| 337 | CGEM | Cullinan Therapeutics, Inc. | 1.42B | -1.16% | 41,508 | - |
| 338 | ALMS | Alumis Inc. | 1.42B | 5.89% | 985,437 | 7.40M |
| 339 | ATEC | Alphatec Holdings, Inc. | 1.41B | -0.49% | 149,393 | 815.05M |
| 340 | TNDM | Tandem Diabetes Care, Inc. | 1.41B | -1.41% | 70,434 | 1.04B |
| 341 | LTGO | Latigo Biotherapeutics, Inc. | 1.40B | 1.52% | 9,030 | - |
| 342 | OMER | Omeros Corporation | 1.38B | 1.41% | 84,411 | 38.42M |
| 343 | AZTA | Azenta, Inc. | 1.37B | -1.54% | 49,618 | 613.81M |
| 344 | OMDA | Omada Health, Inc. | 1.37B | -4.33% | 143,784 | 309.76M |
| 345 | SVRA | Savara Inc. | 1.36B | -2.01% | 116,628 | - |
| 346 | MGTX | MeiraGTx Holdings plc | 1.35B | -0.07% | 82,494 | 397.50M |
| 347 | SPTX | Seaport Therapeutics, Inc. | 1.34B | 0.64% | 20,514 | - |
| 348 | ORIC | ORIC Pharmaceuticals, Inc. | 1.34B | -1.71% | 65,476 | - |
| 349 | DRTS | Alpha Tau Medical Ltd. | 1.33B | 0.84% | 208,473 | - |
| 350 | NUTX | Nutex Health Inc. | 1.33B | 0.91% | 19,162 | 846.72M |
| 351 | PNTG | The Pennant Group, Inc. | 1.32B | -0.55% | 12,857 | 1.10B |
| 352 | JBIO | Jade Biosciences, Inc. | 1.30B | -4.30% | 261,047 | - |
| 353 | ODTX | Odyssey Therapeutics, Inc. | 1.29B | 1.35% | 22,298 | 99.00K |
| 354 | MLTX | MoonLake Immunotherapeutics | 1.29B | 0.53% | 74,890 | - |
| 355 | MNKD | MannKind Corporation | 1.28B | -1.36% | 163,211 | 393.63M |
| 356 | IART | Integra LifeSciences Holdings Corporation | 1.28B | -1.99% | 71,249 | 1.65B |
| 357 | IMTX | Immatics N.V. | 1.28B | -1.37% | 21,614 | 47.65M |
| 358 | AORT | Artivion, Inc. | 1.28B | -0.57% | 21,606 | 471.47M |
| 359 | CERT | Certara, Inc. | 1.26B | - | 99,283 | 421.75M |
| 360 | AMN | AMN Healthcare Services, Inc. | 1.25B | -2.94% | 58,294 | 3.43B |
| 361 | OPK | OPKO Health, Inc. | 1.24B | -1.78% | 559,454 | 587.90M |
| 362 | PRCT | PROCEPT BioRobotics Corporation | 1.23B | -2.03% | 89,251 | 337.34M |
| 363 | GLUE | Monte Rosa Therapeutics, Inc. | 1.22B | 0.21% | 32,918 | 28.73M |
| 364 | JANX | Janux Therapeutics, Inc. | 1.20B | -0.15% | 41,665 | 24.00M |
| 365 | BVS | Bioventus Inc. | 1.19B | -1.18% | 121,153 | 581.85M |
| 366 | CRVS | Corvus Pharmaceuticals, Inc. | 1.19B | -0.14% | 32,998 | - |
| 367 | CRON | Cronos Group Inc. | 1.19B | -0.46% | 207,116 | 179.09M |
| 368 | GDRX | GoodRx Holdings, Inc. | 1.19B | 0.87% | 74,396 | 785.23M |
| 369 | TDOC | Teladoc Health, Inc. | 1.18B | 0.54% | 287,985 | 2.49B |
| 370 | USPH | U.S. Physical Therapy, Inc. | 1.17B | -0.12% | 17,222 | 804.27M |
| 371 | KURA | Kura Oncology, Inc. | 1.16B | -0.53% | 150,869 | 77.23M |
| 372 | SANA | Sana Biotechnology, Inc. | 1.16B | -0.77% | 166,120 | - |
| 373 | STAA | STAAR Surgical Company | 1.15B | -0.61% | 28,095 | 339.59M |
| 374 | ENOV | Enovis Corporation | 1.14B | -1.98% | 174,022 | 2.30B |
| 375 | LMRI | Lumexa Imaging Holdings, Inc. | 1.12B | -0.60% | 25,306 | 1.04B |
| 376 | IVA | Inventiva S.A. | 1.12B | -1.85% | 226,060 | 7.94M |
| 377 | IRMD | IRADIMED CORPORATION | 1.10B | -0.31% | 9,862 | 86.34M |
| 378 | SLDB | Solid Biosciences Inc. | 1.09B | -1.31% | 40,865 | - |
| 379 | ATTO | Attovia Therapeutics, Inc. | 1.06B | 7.00% | 15,943 | 1.35M |
| 380 | PCRX | Pacira BioSciences, Inc. | 1.05B | -0.83% | 53,495 | 746.16M |
| 381 | OBX | Obsidian Therapeutics, Inc. | 1.04B | -0.88% | 6,351 | - |
| 382 | AVTX | Avalo Therapeutics, Inc. | 1.02B | -1.19% | 43,795 | 59.00K |
| 383 | ABUS | Arbutus Biopharma Corporation | 1.01B | 0.39% | 324,480 | 181.72M |
| 384 | GERN | Geron Corporation | 1.01B | -1.26% | 668,406 | 204.56M |
| 385 | GMRS | GMR Solutions Inc. | 1.01B | 1.37% | 31,100 | 5.88B |
| 386 | CADL | Candel Therapeutics, Inc. | 1.00B | -0.53% | 52,979 | - |
| 387 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.00B | 0.45% | 129,917 | 41.47M |
| 388 | FTH | Faeth Therapeutics, Inc. | 998.47M | -1.23% | 25,657 | - |
| 389 | IMMX | Immix Biopharma, Inc. | 995.11M | -0.36% | 101,803 | - |
| 390 | AMPH | Amphastar Pharmaceuticals, Inc. | 993.47M | -1.62% | 18,793 | 730.02M |
| 391 | CSTL | Castle Biosciences, Inc. | 989.19M | -3.11% | 18,815 | 357.28M |
| 392 | SGP | SpyGlass Pharma, Inc. | 966.14M | 2.14% | 6,986 | - |
| 393 | DSGN | Design Therapeutics, Inc. | 961.88M | -1.03% | 31,494 | - |
| 394 | WVE | Wave Life Sciences, Inc. | 947.80M | -1.43% | 353,985 | 65.37M |
| 395 | OLMA | Olema Pharmaceuticals, Inc. | 946.72M | -0.09% | 110,805 | - |
| 396 | CBLL | CeriBell, Inc. | 944.10M | -0.85% | 50,951 | 101.96M |
| 397 | QDEL | QuidelOrtho Corporation | 942.91M | -1.43% | 70,385 | 2.67B |
| 398 | ANNX | Annexon, Inc. | 938.42M | 0.41% | 154,877 | - |
| 399 | ARDX | Ardelyx, Inc. | 931.96M | -1.58% | 312,387 | 450.89M |
| 400 | RIGL | Rigel Pharmaceuticals, Inc. | 929.51M | 0.69% | 12,670 | 276.79M |
| 401 | ACRS | Aclaris Therapeutics, Inc. | 905.27M | -0.49% | 94,041 | 8.22M |
| 402 | ANL | Adlai Nortye Group Ltd. | 903.50M | 1.26% | 7,013 | 18.06M |
| 403 | TBPH | Theravance Biopharma, Inc. | 886.77M | 0.06% | 32,869 | 104.31M |
| 404 | SLN | Silence Therapeutics plc | 878.45M | -1.35% | 101,448 | 615.00K |
| 405 | HSTM | HealthStream, Inc. | 872.81M | 0.27% | 9,587 | 321.12M |
| 406 | BBNX | Beta Bionics, Inc. | 871.00M | -0.28% | 78,247 | 119.01M |
| 407 | ACHV | Achieve Life Sciences, Inc. | 868.50M | -0.47% | 100,954 | - |
| 408 | CBIO | Crescent Biopharma, Inc. | 860.30M | 8.41% | 63,040 | 11.88M |
| 409 | INMD | InMode Ltd. | 854.16M | -0.60% | 21,950 | 374.63M |
| 410 | SIBN | SI-BONE, Inc. | 848.42M | -1.20% | 52,017 | 213.60M |
| 411 | AVR | Anteris Technologies Global Corp. | 837.17M | - | 71,110 | 2.24M |
| 412 | HELP | Cybin Inc. | 835.81M | -4.27% | 142,103 | - |
| 413 | AHCO | AdaptHealth Corp. | 816.46M | 1.32% | 157,083 | 3.36B |
| 414 | DBVT | DBV Technologies S.A. | 813.62M | -0.44% | 25,751 | 5.04M |
| 415 | GLAS | Glass House Brands Inc. | 810.96M | 0.64% | 35,926 | 176.98M |
| 416 | CLYM | Climb Bio, Inc. | 806.98M | -6.64% | 1,854,105 | - |
| 417 | CTMX | CytomX Therapeutics, Inc. | 804.05M | -0.81% | 411,159 | 18.30M |
| 418 | PHAR | Pharming Group N.V. | 796.14M | 1.12% | 401 | 366.48M |
| 419 | FDMT | 4D Molecular Therapeutics, Inc. | 792.75M | -3.95% | 46,311 | 92.01M |
| 420 | MNPR | Monopar Therapeutics Inc. | 791.83M | 1.45% | 14,529 | - |
| 421 | VREX | Varex Imaging Corporation | 778.89M | 0.05% | 80,419 | 865.00M |
| 422 | AURA | Aura Biosciences, Inc. | 777.27M | -0.07% | 29,278 | - |
| 423 | COLL | Collegium Pharmaceutical, Inc. | 773.52M | -2.22% | 51,950 | 808.21M |
| 424 | NVCT | Nuvectis Pharma, Inc. | 769.09M | -1.32% | 14,567 | - |
| 425 | NGNE | Neurogene Inc. | 764.84M | -0.36% | 15,299 | 925.00K |
| 426 | AHG | Akso Health Group | 763.95M | 4.91% | 596 | 13.83M |
| 427 | OCS | Oculis Holding AG | 743.87M | 0.25% | 10,403 | 1.45M |
| 428 | ASMB | Assembly Biosciences, Inc. | 739.29M | -1.12% | 7,336 | 74.85M |
| 429 | ZVRA | Zevra Therapeutics, Inc. | 737.55M | 0.98% | 54,879 | 136.07M |
| 430 | VSTM | Verastem, Inc. | 731.75M | 0.75% | 167,599 | 87.53M |
| 431 | MPLT | MapLight Therapeutics, Inc. | 729.71M | 0.54% | 19,007 | - |
| 432 | PHAT | Phathom Pharmaceuticals, Inc. | 726.79M | -1.19% | 32,887 | 239.66M |
| 433 | IRWD | Ironwood Pharmaceuticals, Inc. | 717.14M | -1.59% | 140,920 | 389.32M |
| 434 | SOPH | SOPHiA GENETICS SA | 711.67M | 0.97% | 153,139 | 86.17M |
| 435 | DRUG | Bright Minds Biosciences Inc. | 705.94M | -0.93% | 5,445 | - |
| 436 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 701.52M | -1.57% | 11,201 | - |
| 437 | OABI | OmniAb, Inc. | 694.97M | -5.16% | 241,968 | 38.46M |
| 438 | PHR | Phreesia, Inc. | 692.29M | -5.49% | 187,869 | 507.79M |
| 439 | CTEV | Claritev Corporation | 686.88M | 0.75% | 14,760 | 994.67M |
| 440 | SSII | SS Innovations International, Inc. | 685.99M | 0.69% | 2,161 | 52.40M |
| 441 | STTK | Shattuck Labs, Inc. | 685.48M | -1.16% | 32,955 | 1.00M |
| 442 | EVO | Evotec SE | 681.16M | 0.79% | 30,282 | 819.47M |
| 443 | ALLO | Allogene Therapeutics, Inc. | 678.89M | -0.76% | 520,682 | 4.64M |
| 444 | GYRE | Gyre Therapeutics, Inc. | 678.62M | 0.63% | 13,123 | 109.82M |
| 445 | SGMT | Sagimet Biosciences Inc. | 678.15M | -0.73% | 115,535 | - |
| 446 | AGMB | AgomAb Therapeutics NV | 676.17M | 0.51% | 5,893 | - |
| 447 | CRMD | CorMedix Inc. | 673.44M | 0.35% | 126,320 | 462.25M |
| 448 | AQST | Aquestive Therapeutics, Inc. | 668.98M | -0.93% | 203,245 | 54.09M |
| 449 | VALN | Valneva SE | 656.63M | 0.42% | 22,517 | 163.30M |
| 450 | MDXG | MiMedx Group, Inc. | 651.55M | -1.76% | 125,589 | 355.17M |
| 451 | CTNM | Contineum Therapeutics, Inc. | 648.96M | 0.06% | 15,761 | - |
| 452 | ANGO | AngioDynamics, Inc. | 633.21M | -1.92% | 23,307 | 320.17M |
| 453 | CABA | Cabaletta Bio, Inc. | 632.40M | 4.48% | 1,324,689 | - |
| 454 | ALT | Altimmune, Inc. | 632.18M | -0.91% | 352,789 | 31.00K |
| 455 | PRME | Prime Medicine, Inc. | 631.56M | -3.27% | 214,235 | 4.07M |
| 456 | ARVN | Arvinas, Inc. | 619.86M | -1.15% | 39,657 | 316.70M |
| 457 | RGNX | REGENXBIO Inc. | 614.58M | -3.02% | 107,292 | 174.48M |
| 458 | BLSM | BlossomHill Therapeutics, Inc. | 611.34M | 2.94% | 10,940 | - |
| 459 | TLRY | Tilray Brands, Inc. | 608.91M | -0.66% | 1,094,058 | 915.45M |
| 460 | AUTL | Autolus Therapeutics plc | 604.19M | 1.34% | 258,095 | 117.39M |
| 461 | EIKN | Eikon Therapeutics, Inc. | 603.94M | -2.02% | 36,853 | - |
| 462 | STLN | Starling Oncology, Inc. | 596.21M | -3.94% | 121,367 | 587.24M |
| 463 | EOLS | Evolus, Inc. | 594.45M | -0.66% | 73,906 | 316.49M |
| 464 | CTKB | Cytek Biosciences, Inc. | 590.12M | -3.20% | 60,838 | 206.71M |
| 465 | KIDS | OrthoPediatrics Corp. | 587.73M | -1.27% | 32,372 | 252.72M |
| 466 | TECX | Tectonic Therapeutic, Inc. | 585.89M | -1.35% | 16,678 | - |
| 467 | WEAV | Weave Communications, Inc. | 584.79M | - | 336,384 | 257.79M |
| 468 | PROK | ProKidney Corp. | 581.97M | 0.79% | 78,033 | 818.00K |
| 469 | SPRY | ARS Pharmaceuticals, Inc. | 581.77M | 0.52% | 109,423 | 116.93M |
| 470 | SCTX | Scribe Therapeutics Inc. | 575.36M | -1.29% | 18,362 | 36.28M |
| 471 | BWAY | BrainsWay Ltd. | 574.80M | 0.14% | 9,653 | 60.70M |
| 472 | DCTH | Delcath Systems, Inc. | 566.98M | -1.45% | 24,498 | 95.42M |
| 473 | OVID | Ovid Therapeutics Inc. | 548.79M | 3.69% | 129,636 | 1.58M |
| 474 | CAPR | Capricor Therapeutics, Inc. | 547.67M | -4.75% | 730,340 | 11.13M |
| 475 | PRLD | Prelude Therapeutics Incorporated | 544.84M | -2.58% | 65,810 | 22.42M |
| 476 | FLGT | Fulgent Genetics, Inc. | 542.60M | -1.60% | 51,543 | 323.93M |
| 477 | ARTV | Artiva Biotherapeutics, Inc. | 539.75M | -2.39% | 43,417 | 251.00K |
| 478 | KYTX | Kyverna Therapeutics, Inc. | 532.16M | -0.12% | 52,224 | - |
| 479 | ZURA | Zura Bio Limited | 528.02M | -2.82% | 99,907 | - |
| 480 | NPCE | NeuroPace, Inc. | 522.24M | 0.16% | 16,477 | 106.99M |
| 481 | CERS | Cerus Corporation | 515.90M | -1.54% | 95,658 | 221.55M |
| 482 | SENS | Senseonics Holdings, Inc. | 512.35M | -2.52% | 117,447 | 48.55M |
| 483 | ENTX | Entera Bio Ltd. | 509.90M | 0.86% | 13,163 | 42.00K |
| 484 | TCMD | Tactile Systems Technology, Inc. | 507.41M | -0.05% | 24,663 | 350.31M |
| 485 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 4.81M |
| 486 | PBYI | Puma Biotechnology, Inc. | 495.55M | -0.93% | 24,531 | 231.24M |
| 487 | PRTA | Prothena Corporation plc | 493.86M | -0.67% | 22,667 | 54.53M |
| 488 | EPRX | Eupraxia Pharmaceuticals Inc. | 490.48M | - | 81,826 | - |
| 489 | KMDA | Kamada Ltd. | 484.30M | -1.79% | 15,223 | 191.85M |
| 490 | RZLT | Rezolute, Inc. | 471.15M | -1.10% | 65,545 | - |
| 491 | SRTA | Strata Critical Medical, Inc. | 470.64M | -1.30% | 82,946 | 255.98M |
| 492 | RLMD | Relmada Therapeutics, Inc. | 466.15M | -3.74% | 111,323 | - |
| 493 | EVH | Evolent Health, Inc. | 465.24M | -2.72% | 187,496 | 2.10B |
| 494 | NRC | NRC Health | 464.51M | 4.95% | 19,392 | 140.00M |
| 495 | EDIT | Editas Medicine, Inc. | 463.81M | -1.95% | 229,523 | 47.01M |
| 496 | SGHT | Sight Sciences, Inc. | 462.74M | -0.24% | 20,228 | 83.38M |
| 497 | ARCT | Arcturus Therapeutics Holdings Inc. | 458.75M | -3.58% | 146,348 | 29.37M |
| 498 | DNA | Ginkgo Bioworks Holdings, Inc. | 458.59M | -3.13% | 84,837 | 132.42M |
| 499 | CCCC | C4 Therapeutics, Inc. | 457.65M | -1.85% | 191,486 | 35.04M |
| 500 | AVIR | Atea Pharmaceuticals, Inc. | 453.56M | -0.79% | 22,526 | - |